According to Ken Fisher, the founder and executive chairman of Fisher Investments, American investors continue to undervalue global diversity.

Thermo Fisher Scientific targets $47.2B revenue and $24.80 EPS with 4% organic growth and Clario acquisition gains. Read why ...

Q4 2025 earnings call recap: revenue, EPS, 2026 guidance, AI partnerships and Clario deal impact—get key takeaways for investors now.

Life sciences company Thermo Fisher (NYSE:TMO) reported Q4 CY2025 results , with sales up 7.2% year on year to $12.22 billion ...

Noble Investment Group has promoted Dustin Fisher to principal and head of acquisitions. In his new role, Fisher will lead Noble’s acquisitions strategy, support capital deployment, and help expand ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Fisher Investment's lease at ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced an expansion of its bioprocessing capabilities across Asia, reinforcing its ...

Thermo Fisher Scientific Inc., the world leader in serving science, today announced an expansion of its bioprocessing capabilities across Asia, reinforcing its commitment to supporting the region’s ...

AdventEnergy and L’Fisher Hotel sign retail electricity supply contract. Adventenergy Assistant Vice President for Business Development and Growth Strategy Jonathan Cruz (2nd from left) and L’Fisher ...

Oct 29 (Reuters) - Thermo Fisher (TMO.N), opens new tab said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, strengthening its clinical trial research ...